Loading...
Last update:  November 5, 2019
08:02 +1GMT

Allergenic Molecule  Hev b 5Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE1400.00020130111, Ott H
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE352.86020130605, Simon D
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013BrazilIgE1163.63020130429, Bueno de Sa A
6.2 - General Population (Adults)2012SwedenIgE3710.00020120528, Patelis A
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE992.02020110223, De Knop KJ
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012FranceIgE9755.00020120706, Garnier L
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE960.00020120528, Patelis A
6.5 - Occupational Exposure2012South AfricaIgE853.53020120404, Singh T
10.1 - Normal Control2012BelgiumIgE273.70020110223, De Knop KJ
1.10 - Any allergy symptom, Diagnosed2010ItalyIgE164080.69020100301, Scala E
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010Italy / Austria / Switzerland / NetherlandsIgE10116.83020101118, Bublin M
5.3.1 - Source Exposed (Symptoms, IgE)2010GermanyIgE5250.00020100423, Ott H
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010Italy / Austria / Switzerland / NetherlandsIgE4810.42020101118, Bublin M
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE372.70220090826, Ebo DG
1.1 - Asymptomatic2009BelgiumBPT260.00020091121, Ebo DG
5.3.1 - Source Exposed (Symptoms, IgE)2009BelgiumIgE2277.27020091121, Ebo DG
3.2.1 - Source Sensitized (IgE)2009BelgiumIgE200.00020091121, Ebo DG
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE200.00020091005, Ott H
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2009JapanIgE1442.80020090520, Yagami A
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2009JapanSPT1421.40020090520, Yagami A
3.2.1 - Source Sensitized (IgE)2009ItalyIgE70.00020091030, Quercia O
5.3.1 - Source Exposed (Symptoms, IgE)2008PortugalIgE540.00020080904, Rodrigues Alves R
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2007FinlandIgE7928.00020070910, Palasuo T
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2007SpainIgE7449.00020070910, Palasuo T
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2007United StatesIgE6271.00020070910, Palasuo T
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2006SpainIgE2343.50020060324, Sanz ML
5.3.1 - Source Exposed (Symptoms, IgE)2005SpainIgE3154.80020051208, Pamies R
3.1.2 - Source Sensitized - High Exposure (SPT)2003United StatesSPT6265.0002003, Bernstein DI
5.2.1 - Source Exposed (Symptoms, SPT)2000CanadaSPT2962.1002000, Yip L
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2000United StatesIgE2836.0002000, Yeang HY
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2000FinlandIgE813.0002000, Yeang HY
3.2.2 - Source Sensitized - High Exposure (IgE)1996United StatesIgE5756.0001996, Slater JE
3.2.2 - Source Sensitized - High Exposure (IgE)1996United StatesIgE1392.0001996, Slater JE
Developed by
Panservice